About
StemX Bio produces human iPSC-derived 3D microtissues that replicate native human pancreatic tissue structure and function to improve the predictive power of preclinical drug testing without using animal models.
Explore StemX Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.